Astellas Pharma Inc (OTCPK:ALPMF)
$ 13.05 +3 (+22.99%) Market Cap: 26.34 Bil Enterprise Value: 28.46 Bil PE Ratio: 14.34 PB Ratio: 2.28 GF Score: 77/100

Full Year 2025 Astellas Pharma Inc Earnings Presentation Transcript

Apr 25, 2025 / 08:00AM GMT
Release Date Price: $10.12 (+14.09%)
Hiromitsu Ikeda
Astellas Pharma Inc - Chief Communications & Investor Relations Officer

Thank you very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot